|
|
SPOT ON
|
|
Early benefit assessment: is the Pharmaceutical Market Restructuring Act in Germany (AMNOG) a break on innovation?
|
|
|
NEW ON THE MARKET
|
|
Thrombin inhibitor dabigatran (PRADAXA) for nonvalvular atrial fibrillation
Protease inhibitor boceprevir (VICTRELIS) for chronic hepatitis C
|
|
|
a-t READER'S QUESTIONS AND COMMENTS
|
|
Are pre-filled syringes without integrated needle protection obsolete?
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Liver damage with analgesic flupirtine (KATADOLON, generics)
|
|
|
SIDE EFFECTS
|
|
E.g. clozapine (LEPONEX, generics): bedwetting with atypical antipsychotics in adults
QT interval prolongation with SSRI citalopram (CIPRAMIL, generics)
|
|
|
ERRATUM regarding OPTAFLU
|
|